The overall aims and objectives of the proposed research are several: 1) to understand more precisely the molecular aspects of the interaction of the phosphate ring of cyclic 3 feet,5 feet-nucleoside monophosphates with intracellular enzymes with the ultimate target the normalization of processes which control neoplastic transformation; 2) to devise new potential antitumor and antiviral prodrugs based on cyclic 3 feet,5 feet nucleoside monophosphate; neutral cyclic nucleotide derivatives, and certain 3 feet and 5 feet nucleoside monophosphate diesters; 3) to prepare steriospecifically 0-isotope labeled phosphates of biological interest and then correlate 17-O NMR spectral parameters with phosphorus configuration and conformation; 4) to gain a thorough understanding of the conformational features of the 1,3,2-oxazaphosphoriane ring of cyclophosphamide and diastereomeric ring-substituted derivatives and their realationship to ease of microsomal oxidation potentiation and overall therapeutic selectivity; 5) to survey the synthetic and mechanistic aspects of a newly discovered reaction generating N-substituted azetidines with the potential for preparation of biologically interesting Beta-lactams; 6) to utilize newly discovered and postulated new free radical chain reactions of hydridophosphoranes to prepare pentacovalent phosphorous products not otherwise easily available. To these ends new synthetic methods based on cyclic tervalent phosphorus intermediates will be devised for the preparation of neutral derivatives of 3feet,5 feet-cyclic nucleoside monophosphates with a variety of functionality at phosphorus. Collaborative testing in enzyme, cellular and in vivo systems will be carried out, including the assessment of antitumor and antiviral properties. 1H, 13C, and 31p NMR techniques will be to characterize the phosphate ring conformations of the neutral cyclic nucleotide derivatives, assign phosphorus configuration, and relate geometry to biological activity. NMR techniques similarly will be applied to the 1,3,2-oxazaphosphorinane ring system of cyclophosphamide and key ring-substituted derivatives. 17O NMR techniques will be applied in both systems to molecules prepared by stereospecific reaction pathways.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA011045-17
Application #
3163433
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Project Start
1975-06-01
Project End
1989-05-31
Budget Start
1985-06-01
Budget End
1986-05-31
Support Year
17
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
Schools of Arts and Sciences
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Nelson, K A; Bentrude, W G (1992) Nucleoside cyclic 3',5'-phosphates: chair-twist equilibria of the phosphate rings of methyl phosphate and phenylphosphonate derivatives of cTMP. Carbohydr Res 234:141-56
Mullah, K B; Rao, T S; Balzarini, J et al. (1992) Potential prodrug derivatives of 2',3'-didehydro-2',3'-dideoxynucleosides. Preparations and antiviral activities. J Med Chem 35:2728-35
Beres, J; Bentrude, W G; Otvos, L et al. (1989) Synthesis and cytostatic and antiviral activities of 1-beta-D-ribofuranosyl-5-alkylcytosine (5-alkylcytidine) cyclic 3',5'-monophosphates. J Med Chem 32:224-8
De Clercq, E; Beres, J; Bentrude, W G (1987) Potent activity of 5-fluoro-2'-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase. Mol Pharmacol 32:286-92
Beres, J; Bentrude, W G; Balzarini, J et al. (1986) Synthesis and antitumor and antiviral properties of 5-alkyl-2'-deoxyuridines, 3',5'-cyclic monophosphates, and neutral cyclic triesters. J Med Chem 29:494-9
Beres, J; Bentrude, W G; Kalman, A et al. (1986) Synthesis, structure, and antitumor and antiviral activities of a series of 5-halouridine cyclic 3',5'-monophosphates. J Med Chem 29:488-93
Beres, J; Sagi, G; Bentrude, W G et al. (1986) Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters. J Med Chem 29:1243-9
Beres, J; Bentrude, W G; Kruppa, G et al. (1985) Synthesis and antitumor and antiviral activities of a series of 1-beta-D-ribofuranosyl-5-halocytosine (5-halocytidine) cyclic 3',5'-monophosphates. J Med Chem 28:418-22